Indication

SOTYKTU SAFETY & SIDE EFFECTS

As with all prescription medicines, some side effects are possible with SOTYKTU, and it's important to be aware of them.

Expand the sections below for more information about potential side effects and important considerations for anyone taking SOTYKTU.

The most common side effects of SOTYKTU include:
  • common cold, sore throat, and sinus infection (upper respiratory infections)
  • cold sores (herpes simplex)
  • sores on inner lips, gums, tongue, or roof of the mouth (canker sores)
  • inflamed hair pores (folliculitis)
  • acne

These are not all of the possible side effects of SOTYKTU.
Serious side effects may occur. Call your dermatology specialist for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Accompanying chart depicts side effects experienced by at least 1% of people who took SOTYKTU in clinical trials, out of a total 1684 participants.

Most common side effects experienced
(through Week 16)

The most common side effects of SOTYKTU® are common cold, sore throat, sinus infection, cold sores, canker sores, inflamed hair pores, and acne.

In studies, at 16 weeks, 2.4% of people stopped taking SOTYKTU due to side effects compared to 3.8% for placebo. A placebo is a pill with no medicine.

What is the most important information I should know about SOTYKTU?

SOTYKTU may cause serious side effects, including:

  • Serious allergic reactions.  Stop taking SOTYKTU and get emergency medical help right away if you develop any of the following symptoms of a serious allergic reaction:
    • feel faint
    • trouble breathing or throat tightness
    • swelling of your face, eyelids, lips, mouth, tongue, or throat
    • chest tightness
    • skin rash, hives
  • Infections. SOTYKTU is a medicine that affects your immune system. SOTYKTU can lower the ability of your immune system to fight infections and can increase your risk of infections. Some people have had serious infections while taking SOTYKTU, such as infections of the lungs, including pneumonia and tuberculosis (TB), and COVID-19.
    • Your healthcare provider should check you for infections and TB before starting treatment with SOTYKTU.
    • Your healthcare provider may treat you for TB before you begin treatment with SOTYKTU if you have a history of TB or have active TB.
    • Your healthcare provider should watch you closely for signs and symptoms of TB during treatment with SOTYKTU.
    • If you get a serious infection, your healthcare provider may tell you to stop taking SOTYKTU until your infection is controlled.

SOTYKTU should not be used in people with an active, serious infection, including localized infections. You should not start taking SOTYKTU if you have any kind of infection unless your healthcare provider tells you it is okay.
You may be at a higher risk of developing shingles (herpes zoster).

Before starting SOTYKTU, tell your healthcare provider if you:

  • are being treated for an infection
  • have had an infection that does not go away or keeps coming back
  • have TB or have been in close contact with someone with TB
  • have or have had hepatitis B or C
  • think you have an infection or have symptoms of an infection such as:
    • fever, sweats, or chills
    • muscle aches
    • weight loss
    • cough
    • shortness of breath
    • blood in your phlegm (mucus)
    • warm, red, or painful skin or sores on your body different from your psoriasis
    • diarrhea or stomach pain
    • burning when you urinate or urinating more often than normal
    • feeling very tired

After you start taking SOTYKTU, call your healthcare provider right away if you have an infection or have symptoms of an infection. SOTYKTU can make you more likely to get infections or make any infections you have worse.

  • Cancer. Certain kinds of cancer including lymphoma have been reported in people taking SOTYKTU.
    • Tell your healthcare provider if you have ever had any type of cancer.
  • Muscle problems (rhabdomyolysis). SOTYKTU can cause muscle problems that can be severe. Treatment with SOTYKTU may increase the level of an enzyme in your blood called creatine phosphokinase (CPK) and can be a sign of muscle damage. Increased CPK is common in people taking SOTYKTU. Your healthcare provider may tell you to stop taking SOTYKTU if the amount of CPK in your blood gets too high or if you have signs and symptoms of severe muscle problems. Tell your healthcare provider right away if you have any of these signs or symptoms of severe muscle problems:
    • unexplained muscle pain, tenderness, or weakness
    • feeling very tired
    • fever
    • dark-colored urine

Do not take SOTYKTU if you are allergic to deucravacitinib or any of the ingredients in SOTYKTU.

Before taking SOTYKTU, tell your healthcare provider about all of your medical conditions, including if you:

  • have liver problems or kidney problems
  • have high levels of fat in your blood (triglycerides)
  • have recently received or are scheduled to receive an immunization (vaccine). You should avoid receiving live vaccines during treatment with SOTYKTU.
  • are pregnant or plan to become pregnant. It is not known if SOTYKTU can harm your unborn baby.
    • Report pregnancies to the Bristol-Myers Squibb Company’s Adverse Event reporting line at 1-800-721-5072.
  • are breastfeeding or plan to breastfeed. It is not known if SOTYKTU passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

What are the possible side effects of SOTYKTU?

SOTYKTU may cause serious side effects, including:

  • Changes in certain laboratory test results. Changes in laboratory tests have happened in some people taking SOTYKTU. Your healthcare provider may do blood tests before you start taking SOTYKTU and during treatment with SOTYKTU to check for the following:
    • Increased triglycerides. Triglycerides are a type of fat found in your blood. Too much fat in your blood can cause problems with your heart.
    • Increased liver enzymes. Liver enzymes are found in your blood and help to tell if your liver is functioning normally. If your liver enzymes increase too much, your healthcare provider may need to do additional tests on your liver and may tell you to stop taking SOTYKTU if they think that SOTYKTU is harming your liver.
  • Potential risks from Janus kinase (JAK) inhibition. SOTYKTU is a tyrosine kinase 2 (TYK2) inhibitor. TYK2 is in the JAK family. It is not known whether taking SOTYKTU has the same risks as taking JAK inhibitors. Increased risk of death (all causes) has happened in people who were 50 years of age and older with at least 1 heart disease (cardiovascular) risk factor who were taking a JAK inhibitor used to treat rheumatoid arthritis (RA) compared to people taking another medicine in a class of medicines called TNF blockers. SOTYKTU is not for use in people with RA.

CONCERNED ABOUT SIDE EFFECTS?

It’s a good topic to discuss with your dermatology specialist. Here are some others.

MEET EMILY AND DAVID

They’re both currently taking SOTYKTU. Hear about their experiences


Bristol Myers Squibb corporate website

SOTYKTU, SOTYKTU 360 SUPPORT, and SOTYKTU logo are trademarks of Bristol-Myers Squibb Company.
All other trademarks are property of their respective owners.
© 2024 Bristol-Myers Squibb Company.

This website is intended for U.S. residents 18 years of age or older.

1787-US-2400591 12/24